Uncovering Novel Therapeutic Targets for Parkinson’s Disease

Uncovering Novel Therapeutic Targets for Parkinson’s Disease
ACS Chem Neurosci. 2023 May 25. doi: 10.1021/acschemneuro.3c00084. Online ahead of print.ABSTRACTParkinson's disease (PD) is the second most prevailing progressive disorder leading to neurodegeneration, typically in people above 65 years of age. Motor clinical manifestations of PD appear in a much later stage and include rigidity, tremors, akinesia, and gait dysfunction. There are also nonmotor symptoms like GI and olfactory ... read more
Source: PubMedPublished on 2023-05-25By Ritu Soni